Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 128 results found. Search for [ Pfizer coronavirus shot ]

Results 1 to 21 of 128
Reuters
March 1, 2021
\"The real motivation here is actually exfiltrating intellectual property and getting a competitive advantage over Indian pharmaceutical companies,\" says Cyfirma Chief Executive Kumar Ritesh


PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator


Associated Press
February 27, 2021
The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US


Reuters
February 23, 2021
Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose


Reuters
February 23, 2021
Pfizer has shipped around 40 million doses to locations across the United States so far and is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer's chief business officer


Reuters
February 19, 2021
Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response


Reuters
February 19, 2021
Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine is highly likely to still protect against the concerning variant first discovered in South Africa


Rashi Bisaria
New Delhi, February 18, 2021
South African variant could significantly reduce vaccine protection, says Pfizer A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer-BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. Companies are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed. COV...


Reuters
February 18, 2021
Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil


Reuters
February 15, 2021
South Korea had said it would complete vaccinations on 1.3 million people by the first quarter of this year with AstraZeneca shots, but it slashed the target sharply to 750,000


Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data


BusinessToday.In
February 9, 2021
WHO highlighted the need to reduce virus circulation and prevent infections so that it reduces the opportunities for coronavirus to mutate further.


BusinessToday.In
February 8, 2021
Coronavirus vaccine: Sarah Gilbert, professor of vaccinology at Oxford told BBC that the researchers have already started working on the first part of the manufacturing process


Reuters
February 8, 2021
Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%, researchers said


PTI
February 6, 2021
Andrew Pollard of Oxford University, which helped develop the AstraZeneca vaccine, says the shot also appears to reduce the amount of virus in people infected with COVID-19


BusinessToday.In
February 5, 2021
Coronavirus vaccine: Pfizer was the first pharmaceutical company to seek EUA from Drugs Controller General of India (DCGI) after its vaccine was approved in the UK and Bahrain


PB Jayakumar
February 4, 2021
Coronavirus vaccine: India will get the maximum share of 97,164,000 doses (97.1 million), in addition to the direct orders placed by the Indian government with SII and Bharat Biotech


PTI
February 4, 2021
The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity to the novel coronavirus


Reuters
February 4, 2021
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world


Associated Press
January 30, 2021
Vaccines are not yet approved for children, but testing already is underway for those as young as 12


PAGES 1 OF 7  12345